Glucocorticoids and treatment of prostate cancer: a preclinical and clinical review

Urology. 2002 Oct;60(4):553-61. doi: 10.1016/s0090-4295(02)01741-7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / metabolism
  • Androgen Antagonists / metabolism
  • Androgen Antagonists / pharmacology
  • Androgen Antagonists / therapeutic use
  • Annexins / drug effects
  • Annexins / metabolism
  • Antineoplastic Agents, Hormonal / pharmacology
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Apoptosis / drug effects
  • Cell Division / drug effects
  • Clinical Trials as Topic
  • Clinical Trials, Phase II as Topic
  • Clinical Trials, Phase III as Topic
  • Glucocorticoids / pharmacology
  • Glucocorticoids / therapeutic use*
  • Humans
  • Male
  • Neoplasms, Hormone-Dependent / drug therapy
  • Neoplasms, Hormone-Dependent / metabolism
  • Neoplasms, Hormone-Dependent / physiopathology
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / metabolism
  • Prostatic Neoplasms / physiopathology
  • Retrospective Studies
  • Transcription, Genetic / drug effects
  • Transforming Growth Factor beta / drug effects
  • Transforming Growth Factor beta / metabolism
  • Treatment Outcome
  • Tumor Cells, Cultured

Substances

  • Androgen Antagonists
  • Annexins
  • Antineoplastic Agents, Hormonal
  • Glucocorticoids
  • Transforming Growth Factor beta